Filing Details

Accession Number:
0001628280-22-026521
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2022-10-17 17:50:38
Reporting Period:
2022-10-06
Accepted Time:
2022-10-17 17:50:38
Original Submission Date:
2022-10-11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1807794 Credo Technology Group Holding Ltd CRDO () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1008463 Bu Lip Tan 1600 Technology Drive
San Jose CA 95110
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2022-10-06 107,550 $11.68 5,803,977 No 4 S Indirect Celesta Capital II, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Celesta Capital II, L.P.
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to Rule 144.
  2. This transaction was executed in multiple trades at prices ranging from $11.65 to $11.8050. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. The Reporting Person is the Managing Director of Celesta Capital GP II, Ltd., which is the general partner of Celesta Capital II, L.P. The Reporting Person disclaims beneficial ownership of these indirectly held shares except to the extent of any pecuniary interest therein. Represents restricted stock units that will vest over a period of four years subject to continued employment through each vesting date.
  4. On October 10, 2022, the Reporting Person inadvertently reported this sale as having been attributed to Celesta Capital III, L.P. In fact, as reported in this amendment, the Reporting Person is correctly stating that this sale was made by Celesta Capital II, L.P.